Clinical Trials for Ambrx

Explore 2 clinical trials worldwide

Showing 1-2 of 2 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Ambrx

Clinical Trials (2)

NCT06224673
ARX788 for Treating Patients With HER2-low Locally Advanced Unresectable or Metastatic Breast Cancer
PHASE2Not yet recruiting
36 participants
Started: Oct 1, 2025 · Completed: Dec 31, 2028
4 conditions2 sponsors1 location
NCT04829604
ARX788 in HER2-positive, Metastatic Breast Cancer Subjects (ACE-Breast-03)
PHASE2Recruiting
71 participants
Started: Oct 26, 2021 · Completed: Jun 30, 2027
1 condition1 sponsor64 locations